fda
6 records
FDA Recall: Cepheid — Class II
20251224
Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results. | Product: Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog Number: GX...
View Source
FDA Recall: Cepheid — Class II
20251203
Product testing did not meet expected stability criteria. | Product: Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.
View Source
FDA Device Recall: Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog Number: GXBCRABL-10
2025-12-24
Class II — Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.
View Source
FDA Device Recall: Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.
2025-12-03
Class II — Product testing did not meet expected stability criteria.
View Source
FDA Device Recall: Cepheid, Sample Collection Device, Part: 900-0370
2024-08-21
Class II — Specimen collection device may leak after the patient sample swabs have been inserted into the test tubes, which could result in biohazard exposure, cross contamination causing false positi...
View Source
FDA Device Recall: Xpert MRSA Catalog GXMRSA-120, Rev. AJ Microbiology: The Cepheid Xpert MR
2016-08-24
Class II — Internal investigation found the certain lots of MRSA kits have the potential for performance issues at lower positive sample concentrations.
View Source
lobbying
3 records
Lobbying Firm: CEPHEID
Registered lobbying firm — Washington, DC — Manufacture and commercialize clinical molecular diagnostic tests
View Source
Lobbying Client: CEPHEID
Lobbied by BROWNSTEIN HYATT FARBER SCHRECK, LLP — Diagnostic testing
View Source
Lobbying Client: CEPHEID
Lobbied by TODD STRATEGY GROUP — Molecular diagnostics company.
View Source
ny_corps
1 records
NY Corp: CEPHEID
2014-02-21
FOREIGN BUSINESS CORPORATION | County: New York | Jurisdiction: California
View Source
USASpending
16 records
Federal Award: CEPHEID — $1,250,000
2025-09-17
NNMC CEPHEID MOLECULAR DIAGNOSTIC TESTING SUPPLIES AND REAGENTS
View Source
Federal Award: CEPHEID — $9,331,878
2024-03-20
MOLECULAR DIAGNOSTIC TESTS FOR SARS-COV-2
View Source
Federal Award: CEPHEID — $1,572,200
2024-02-08
LAB SUPPLIES INCLUSIVE OF TESTING SUPPLIES USING CEPHEID GENEXPERT ANALYZER INCLUDING MICROBIOLOGY SUPPLIES, REAGENT KITS AND COVID-19 TEST KITS, ORDER "AS NEEDED".
View Source
Federal Award: CEPHEID — $2,268,519
2022-08-01
MOLECULAR DIAGNOSTIC TESTING SYSTEM LEASE AND PURCHASE OF INSTRUMENT SPECIFIC ASSAYS
View Source
Federal Award: CEPHEID — $74,983,757
2021-07-23
OTA - PANDEMIC PREPAREDNESS AND RESPONSE: ESTABLISHING A PLATFORM FOR DIAGNOSIS AND SURVEILLANCE OF EMERGING THREATS
View Source
Federal Contractor: CEPHEID
Total awards: $64,534,637 | UEI: W6HQTMWB9Q28 | DUNS: 956711444
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.